Medicilon Logo
search icon search icon language icon contact icon menu icon
Medicilon Logo
search icon close search icon language icon contact icon menu icon
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Hemolysis Assay Labs

Page View:

Hemolysis Assay

The hemolysis assay is used to determine the hemolytic effect of a test compound.

Hemolysis Assay
Hemolytic activity is a requirement to be tested for any blood contacting medical device. The test is based on erythrocyte lysis induced by contact, leachables, toxins, metal ions, surface charge or any other cause of erythrocyte lysis. The current description is based on direct contact of biomaterial and an erythrocyte suspension. The method is based on release of hemoglobin, which can be measured spectrophotometrically. This method is suited to evaluate the hemocompatibility of biomaterials and medical devices according to the international standard ISO 10993-4:2002.

The Hemolysis test is designed to determine the hemolytic properties of a medical device/material. This test is performed on medical devices/materials that have direct or indirect blood contact.

  • Evaluate your small molecule, biologic, or formulation excipients for its potential to lyse red blood cells

  • Personalized experimental design to ensure the most relevant data is obtained with the options to examine all relevant in vivo pharmacologically relevant blood from appropriate species

  • All assays are performed with high-quality reagents and strict controls by experienced immunologists

Required from Customer

  • Either a minimum of 300 µL of test compound at 10 mM in DMSO, or 5 mg of powder

  • Molecular mass (exact mass) of the test compound and its salt form

  • MSDS and handling and storage information, e.g., light sensitive, store at -20°C, etc.


  • Percent of hemolysis in each sample

  • Rate of hemolysis, if applicable


  • Test compound dissolved in DMSO applied to a suspension of red blood cells in isotonic buffer or plasma. The final dosing concentration is typically 10 uM or the clinical Cmax

Assay System

  • A suspension of red blood cells from a species specified by the customer

  • The positive control: red blood cells treated with 0.1% SDS (sodium dodecyl sulfate) to produce 100% hemolysis

  • The negative control: red blood cells treated with DMSO

Hemolysis Assay Conditions

  • Prepare three separate test tubes (N=3) containing red blood cells dosed with the test compound dissolved in DMSO

  • Incubated at 37°C in a water bath with mild agitation

  • Sample each replicate at 0, 5, 15, 30, 60, 120 and 180 minutes

  • Centrifuge each sample

  • Measure the absorbance of the supernatant from each sample using a UV/Vis spectrometer

  • Calculate percent hemolysis at each sampling time point

Hemolysis Assay

Hemolysis Assay Dynamic Range

  •  Hemolysis can be determined from between 10 and 100% with a typical precision (N=3) of 10%

Hemolysis Assay QC

  • Positive and negative controls run with each compound


The customer may select:

  • either the basic, standard or custom report format

  • the species of blood donor plasma or isotonic buffer

The customer can request:

  • additional replicates

  • the use of a control buffer in which the stability of the test compound is measured

  • the concentration of the test compound

Related Articles:

Hemolysis Test

Relevant newsRelevant news